Psychemedics Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Psychemedics.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 20.9% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Psychemedics Corporation's (NASDAQ:PMD) Prospects Need A Boost To Lift Shares
Jul 29There's Reason For Concern Over Psychemedics Corporation's (NASDAQ:PMD) Massive 28% Price Jump
Jan 08Psychemedics (NASDAQ:PMD) Is Paying Out A Dividend Of $0.07
May 13Psychemedics GAAP EPS of -$0.06, revenue of $6.51M
Aug 09Psychemedics: 21% Sales Growth But Net Loss, Takeover Possibility, Covid Recovery Play
Apr 25Psychemedics: Q3 Revenues +29%, Margins Surge, Possible Corporate Actions Including Dividend
Nov 18Psychemedics: Market Leader, 8% FCF Yield, Possible Takeover Target
Oct 18Psychemedics reports Q1 results
May 10We Think Psychemedics Corporation's (NASDAQ:PMD) CEO Compensation Package Needs To Be Put Under A Microscope
May 07Here's Why Psychemedics (NASDAQ:PMD) Can Afford Some Debt
Mar 05Psychemedics Corp.: Trucking Along Into A Potential Big Catalyst ($21 PT)
Jan 30How Much Are Psychemedics Corporation (NASDAQ:PMD) Insiders Spending On Buying Shares?
Jan 11Psychemedics reports Q3 results
Nov 09In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Psychemedics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 20 | -3 | 0 | 1 | N/A |
6/30/2024 | 21 | -5 | -1 | -1 | N/A |
3/31/2024 | 22 | -4 | -2 | -2 | N/A |
12/31/2023 | 22 | -4 | -2 | -1 | N/A |
9/30/2023 | 23 | -4 | 0 | 0 | N/A |
6/30/2023 | 24 | -2 | 3 | 3 | N/A |
3/31/2023 | 25 | -2 | 4 | 4 | N/A |
12/31/2022 | 25 | -1 | 5 | 5 | N/A |
9/30/2022 | 26 | -2 | 3 | 4 | N/A |
6/30/2022 | 26 | -1 | 1 | 1 | N/A |
3/31/2022 | 26 | -1 | 1 | 1 | N/A |
12/31/2021 | 25 | -1 | 0 | 0 | N/A |
9/30/2021 | 24 | 0 | 1 | 1 | N/A |
6/30/2021 | 22 | -1 | 0 | 0 | N/A |
3/31/2021 | 20 | -4 | -5 | -4 | N/A |
12/31/2020 | 21 | -4 | -5 | -4 | N/A |
9/30/2020 | 25 | -4 | -6 | -4 | N/A |
6/30/2020 | 29 | -2 | -3 | -1 | N/A |
3/31/2020 | 35 | 1 | 2 | 4 | N/A |
12/31/2019 | 38 | 2 | 3 | 4 | N/A |
9/30/2019 | 39 | 3 | 6 | 7 | N/A |
6/30/2019 | 40 | 4 | 5 | 6 | N/A |
3/31/2019 | 42 | 4 | 6 | 7 | N/A |
12/31/2018 | 43 | 5 | 7 | 8 | N/A |
9/30/2018 | 42 | 6 | 5 | 6 | N/A |
6/30/2018 | 42 | 6 | N/A | 9 | N/A |
3/31/2018 | 40 | 6 | N/A | 6 | N/A |
12/31/2017 | 40 | 6 | N/A | 9 | N/A |
9/30/2017 | 41 | 6 | N/A | 10 | N/A |
6/30/2017 | 43 | 7 | N/A | 10 | N/A |
3/31/2017 | 43 | 8 | N/A | 13 | N/A |
12/31/2016 | 39 | 7 | N/A | 9 | N/A |
9/30/2016 | 34 | 5 | N/A | 9 | N/A |
6/30/2016 | 30 | 3 | N/A | 5 | N/A |
3/31/2016 | 27 | 1 | N/A | 4 | N/A |
12/31/2015 | 27 | 2 | N/A | 5 | N/A |
9/30/2015 | 28 | 2 | N/A | 5 | N/A |
6/30/2015 | 28 | 2 | N/A | 6 | N/A |
3/31/2015 | 29 | 3 | N/A | 5 | N/A |
12/31/2014 | 29 | 3 | N/A | 4 | N/A |
9/30/2014 | 29 | 3 | N/A | 4 | N/A |
6/30/2014 | 28 | 4 | N/A | 4 | N/A |
3/31/2014 | 27 | 4 | N/A | 5 | N/A |
12/31/2013 | 27 | 4 | N/A | 6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if PMD's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if PMD's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if PMD's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if PMD's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if PMD's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PMD's Return on Equity is forecast to be high in 3 years time